Revenue | ₹65.62Cr |
Net Profits | ₹8.50Cr |
Net Profit Margins | 12.95% |
Welcure Drugs & Pharmaceuticals Ltd’s revenue jumped 167.29% since last year same period to ₹65.62Cr in the Q2 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -78.12% fall in its revenue since last 3-months.
Welcure Drugs & Pharmaceuticals Ltd’s net profit jumped 361.96% since last year same period to ₹8.50Cr in the Q2 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -63.52% fall in its net profits since last 3-months.
Welcure Drugs & Pharmaceuticals Ltd’s net profit margin jumped 72.83% since last year same period to 12.95% in the Q2 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated 66.73% jumped in its net profit margins since last 3-months.
The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was ₹65.62Cr.
The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was ₹8.50Cr.
The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was 12.95%.
The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹24.55Cr.
The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹1.84Cr.
The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was 7.49%.